Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma.

Fan S, Liu X, Wu Y, Li K, Zhao X, Lin W, Liu J

Open source

DOI
10.1155/2022/9086540
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/9086540,
  title = {Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma.},
  author = {Fan S and Liu X and Wu Y and Li K and Zhao X and Lin W and Liu J},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/9086540},
  url = {https://doi.org/10.1155/2022/9086540}
}

RIS

TY  - JOUR
TI  - Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma.
AU  - Fan S
AU  - Liu X
AU  - Wu Y
AU  - Li K
AU  - Zhao X
AU  - Lin W
AU  - Liu J
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/9086540
UR  - https://doi.org/10.1155/2022/9086540
ER  - 

APA

S, F., X, L., Y, W., K, L., X, Z., W, L., & J, L. (2022). Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/9086540

Source records